Intravenous or subcutaneous natalizumab in patients with relapsing–remitting multiple sclerosis: investigation on efficiency and savings—the EASIER study.
Saved in:
| Title: | Intravenous or subcutaneous natalizumab in patients with relapsing–remitting multiple sclerosis: investigation on efficiency and savings—the EASIER study. |
|---|---|
| Authors: | Filippi, Massimo1,2 (AUTHOR) filippi.massimo@hsr.it, Grimaldi, Luigi3 (AUTHOR), Conte, Antonella4,5,6 (AUTHOR), Totaro, Rocco7 (AUTHOR), Valente, Maria Rosaria8 (AUTHOR), Malucchi, Simona9 (AUTHOR), Granella, Franco10 (AUTHOR), Cordioli, Cinzia11 (AUTHOR), Brescia Morra, Vincenzo12 (AUTHOR), Zanetta, Chiara1 (AUTHOR), Perini, Daria13 (AUTHOR), Santoni, Laura13 (AUTHOR), the EASIER Study Working Group (AUTHOR), Ziccone, V. (AUTHOR), Garba, R. (AUTHOR), Motta, A. (AUTHOR), Albanesi, S. (AUTHOR), Oddo, O. (AUTHOR), Impagliato, A. (AUTHOR), Ferrazzano, G. (AUTHOR) |
| Source: | Journal of Neurology. Jan2024, Vol. 271 Issue 1, p340-354. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
